1. Home
  2. MLTX vs ALIT Comparison

MLTX vs ALIT Comparison

Compare MLTX & ALIT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MLTX
  • ALIT
  • Stock Information
  • Founded
  • MLTX 2021
  • ALIT 2017
  • Country
  • MLTX Switzerland
  • ALIT United States
  • Employees
  • MLTX N/A
  • ALIT N/A
  • Industry
  • MLTX Biotechnology: Pharmaceutical Preparations
  • ALIT Business Services
  • Sector
  • MLTX Health Care
  • ALIT Consumer Discretionary
  • Exchange
  • MLTX Nasdaq
  • ALIT Nasdaq
  • Market Cap
  • MLTX 2.8B
  • ALIT 3.0B
  • IPO Year
  • MLTX N/A
  • ALIT N/A
  • Fundamental
  • Price
  • MLTX $49.67
  • ALIT $5.55
  • Analyst Decision
  • MLTX Strong Buy
  • ALIT Strong Buy
  • Analyst Count
  • MLTX 7
  • ALIT 7
  • Target Price
  • MLTX $73.33
  • ALIT $9.86
  • AVG Volume (30 Days)
  • MLTX 426.9K
  • ALIT 7.6M
  • Earning Date
  • MLTX 08-06-2025
  • ALIT 08-05-2025
  • Dividend Yield
  • MLTX N/A
  • ALIT 2.91%
  • EPS Growth
  • MLTX N/A
  • ALIT N/A
  • EPS
  • MLTX N/A
  • ALIT N/A
  • Revenue
  • MLTX N/A
  • ALIT $2,321,000,000.00
  • Revenue This Year
  • MLTX $103.42
  • ALIT $2.53
  • Revenue Next Year
  • MLTX N/A
  • ALIT $4.02
  • P/E Ratio
  • MLTX N/A
  • ALIT N/A
  • Revenue Growth
  • MLTX N/A
  • ALIT N/A
  • 52 Week Low
  • MLTX $31.42
  • ALIT $4.49
  • 52 Week High
  • MLTX $58.26
  • ALIT $8.93
  • Technical
  • Relative Strength Index (RSI)
  • MLTX 62.21
  • ALIT 51.63
  • Support Level
  • MLTX $46.37
  • ALIT $5.60
  • Resistance Level
  • MLTX $49.29
  • ALIT $6.04
  • Average True Range (ATR)
  • MLTX 1.91
  • ALIT 0.15
  • MACD
  • MLTX 0.13
  • ALIT -0.01
  • Stochastic Oscillator
  • MLTX 70.19
  • ALIT 40.97

About MLTX MoonLake Immunotherapeutics

MoonLake Immunotherapeutics is a clinical-stage biotechnology company advancing therapies to address unmet needs in inflammatory skin and joint diseases. The company is focused on the development of SLK, a novel tri-specific IL-17A and IL-17F inhibiting Nanobody that has the potential, based on response levels seen in clinical trials, to drive disease modification in dermatology and rheumatology patients.

About ALIT Alight Inc.

Alight Inc is a technology-enabled services company delivering human capital management solutions to many of complex organizations. This includes the implementation and administration of employee benefits (e.g., health, wealth and leaves benefits) solutions, currently operates under one reportable segment, Employer Solutions. The Company completed the Divestiture of Alight's Professional Services segment and Alight's Payroll & HCM Outsourcing business within the Employer Solutions segment. The company operates in USA states and International market too.

Share on Social Networks: